ADP-Ribosylation Factor-Like 17B (ARL17) (Middle Region) Peptide
-
- Target See all ARL17 products
- ARL17 (ADP-Ribosylation Factor-Like 17B (ARL17))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-ARL17 antibody (Catalog #: ARP56258_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- ARL17 (ADP-Ribosylation Factor-Like 17B (ARL17))
- Synonyms
- ARL17 Peptide, ARL17A Peptide, ADP ribosylation factor like GTPase 17B Peptide, ARL17B Peptide
- Background
-
ARL17 is a GTP-binding protein that functions as an allosteric activator of the cholera toxin catalytic subunit, an ADP-ribosyltransferase. ARL17 is involved in protein trafficking, may modulate vesicle budding and uncoating within the Golgi apparatus.
Alias Symbols: ARL17B, ARL17, ARL17A
Protein Size: 177 - Molecular Weight
- 19 kDa
- Gene ID
- 641522
- NCBI Accession
- NM_001039083, NP_001034172
- UniProt
- Q8IVW1
-